2024-09-07 - Analysis Report
##  ABT Stock Analysis Report

**Company:** Abbott Laboratories (ABT) is a global healthcare company developing, manufacturing, and marketing a broad range of healthcare products.

**Performance vs. S&P 500:**
ABT has underperformed the S&P 500 (VOO) by -47.7% since the starting date of the data. This represents a relative underperformance of 14.85% compared to the historical range of underperformance and outperformance against the S&P 500. 

**Recent Price Action:**
* Closing Price: 114.4
* 5-day Moving Average: 113.6
* 20-day Moving Average: 111.45
* 60-day Moving Average: 107.0

The stock is currently trading above all three moving averages, indicating potential bullish momentum in the short term.

**Technical Indicators:**
* **RSI:** 78.29 - The stock is in overbought territory, suggesting potential for a short-term correction.
* **PPO:** 0.08 - A positive PPO value indicates bullish momentum.
* **Delta_Previous_Relative_Divergence:** -8.38 - The recent relative divergence is negative, indicating potential short-term downward pressure. 
* **Expected Return:** 27.09% - This represents the expected return on investment over the next five years based on current market conditions.

**Recent Earnings and Outlook:**

| Date | EPS | Revenue |
|---|---|---|
| 2024-07-31 | 0.74 | 10.38 B$ |
| 2024-05-02 | 0.7 | 9.96 B$ |
| 2023-11-01 | 0.82 | 10.14 B$ |
| 2023-08-03 | 0.79 | 9.98 B$ |
| 2023-07-31 | 0.79 | 9.98 B$ |

The most recent earnings report for Q2 2024 shows an EPS of 0.74, exceeding analysts' expectations of 0.72. Revenue for the quarter came in at 10.38B$, exceeding analysts' expectations of 10.35B$. 

**Overall Analysis:**

ABT's stock is currently in an overbought territory, as indicated by the RSI and recent relative divergence. However, the positive PPO and recent earnings beat suggest continued bullish momentum in the short term.  The stock has underperformed the S&P 500 in the past, but its current expected return indicates potential for future growth. Overall, ABT appears to be a mixed bag for investors. While it may be attractive for short-term gains based on its recent performance, caution should be exercised due to its overbought condition. Investors should monitor the stock closely for any signs of a correction.